Lord, Abbett & Co. LLC Vertex Pharmaceuticals Inc Transaction History

Lord, Abbett & Co. LLC

  • $33.6 Billion
  • Q3 2025

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$421.16 - $509.5 $579,095 - $700,562
-1,375 Reduced 46.66%
1,572 $700,000
Q1 2025

May 13, 2025
SELL
$402.49 - $513.76 $67,618 - $86,311
-168 Reduced 5.39%
2,947 $1.43 Million
Q4 2024

Feb 14, 2025
SELL
$396.64 - $516.74 $65,048 - $84,745
-164 Reduced 5.0%
3,115 $1.25 Million
Q3 2024

Nov 14, 2024
BUY
$460.0 - $505.78 $138,000 - $151,734
300 Added 10.07%
3,279 $1.53 Million
Q2 2024

Oct 07, 2024
SELL
$392.81 - $485.53 $47.6 Million - $58.9 Million
-121,284 Reduced 97.6%
2,979 $1.4 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $47.6 Million - $58.9 Million
-121,284 Reduced 97.6%
2,979 $1.4 Million
Q1 2024

Oct 07, 2024
SELL
$407.69 - $446.08 $942,579 - $1.03 Million
-2,312 Reduced 1.83%
124,263 $51.9 Million
Q1 2024

May 09, 2024
SELL
$407.69 - $446.08 $942,579 - $1.03 Million
-2,312 Reduced 1.83%
124,263 $51.9 Million
Q4 2023

Oct 07, 2024
SELL
$343.0 - $410.68 $35.1 Million - $42 Million
-102,187 Reduced 44.67%
126,575 $51.5 Million
Q4 2023

Feb 12, 2024
SELL
$343.0 - $410.68 $35.1 Million - $42 Million
-102,187 Reduced 44.67%
126,575 $51.5 Million
Q3 2023

Oct 07, 2024
SELL
$338.18 - $362.46 $610,753 - $654,602
-1,806 Reduced 0.78%
228,762 $79.6 Million
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $610,753 - $654,602
-1,806 Reduced 0.78%
228,762 $79.6 Million
Q2 2023

Oct 07, 2024
BUY
$314.42 - $351.91 $12.6 Million - $14.1 Million
39,970 Added 20.97%
230,568 $81.1 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $12.6 Million - $14.1 Million
39,970 Added 20.97%
230,568 $81.1 Million
Q1 2023

Oct 07, 2024
SELL
$283.23 - $323.1 $54.8 Million - $62.5 Million
-193,389 Reduced 50.36%
190,598 $60.1 Million
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $54.8 Million - $62.5 Million
-193,389 Reduced 50.36%
190,598 $60.1 Million
Q4 2022

Oct 07, 2024
BUY
$285.76 - $321.48 $109 Million - $122 Million
381,008 Added 12789.8%
383,987 $111 Million
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $48.8 Million - $54.8 Million
-170,599 Reduced 30.76%
383,987 $111 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $5.95 Million - $6.64 Million
21,734 Added 4.08%
554,586 $161 Million
Q2 2022

Aug 12, 2022
SELL
$234.96 - $292.55 $26 Million - $32.3 Million
-110,555 Reduced 17.18%
532,852 $150 Million
Q1 2022

May 13, 2022
BUY
$221.42 - $260.97 $142 Million - $168 Million
643,407 New
643,407 $168 Million
Q3 2021

Nov 09, 2021
SELL
$181.39 - $202.99 $21.5 Million - $24.1 Million
-118,676 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$187.49 - $221.1 $1.26 Million - $1.49 Million
-6,729 Reduced 5.37%
118,676 $23.9 Million
Q1 2021

May 11, 2021
SELL
$207.02 - $241.31 $26.5 Million - $30.9 Million
-128,154 Reduced 50.54%
125,405 $26.9 Million
Q4 2020

Feb 09, 2021
SELL
$207.01 - $276.09 $35 Million - $46.7 Million
-169,012 Reduced 40.0%
253,559 $59.9 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $1.55 Million - $1.84 Million
6,069 Added 1.46%
422,571 $115 Million
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $21.3 Million - $28 Million
-94,657 Reduced 18.52%
416,502 $121 Million
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $31.7 Million - $39.4 Million
158,833 Added 45.08%
511,159 $122 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $23.1 Million - $31.1 Million
138,762 Added 64.97%
352,326 $77.1 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $1.3 Million - $1.47 Million
-7,849 Reduced 3.54%
213,564 $36.2 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $28.8 Million - $33.3 Million
-174,935 Reduced 44.14%
221,413 $40.6 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $6.58 Million - $7.82 Million
-40,184 Reduced 9.21%
396,348 $72.9 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $142,187 - $179,908
-936 Reduced 0.21%
436,532 $72.3 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $13.1 Million - $15 Million
78,060 Added 21.72%
437,468 $84.3 Million
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $23 Million - $26.8 Million
-157,720 Reduced 30.5%
359,408 $61.1 Million
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $11.3 Million - $13.2 Million
74,795 Added 16.91%
517,128 $84.3 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $32.4 Million - $36.7 Million
-236,025 Reduced 34.79%
442,333 $66.3 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $32.5 Million - $35.6 Million
219,299 Added 47.77%
678,358 $103 Million
Q2 2017

Aug 14, 2017
BUY
N/A
459,059
459,059 $59.2 Million

Others Institutions Holding VRTX

# of Institutions
1,786
Shares Held
231M
Call Options Held
1.83M
Put Options Held
1.21M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $111B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email